BPCE
Bank Pictet & Cie (Europe) Portfolio holdings
AUM $4.68B
1-Year Return
16.47%
This Quarter Return
-4.1%
1 Year Return
+16.47%
3 Year Return
+101.24%
5 Year Return
+155.05%
10 Year Return
+381.72%
AUM
$4.19B
AUM Growth
-$365M
(-8%)
Cap. Flow
-$109M
Cap. Flow
% of AUM
-2.6%
Top 10 Holdings %
Top 10 Hldgs %
46.9%
Holding
204
New
38
Increased
55
Reduced
66
Closed
18
Top Buys
| 1 |
Stryker
SYK
|
+$40M |
| 2 |
AbbVie
ABBV
|
+$16.5M |
| 3 |
Eaton
ETN
|
+$13M |
| 4 |
Procter & Gamble
PG
|
+$9.94M |
| 5 |
Marsh & McLennan
MMC
|
+$8.94M |
Top Sells
| 1 |
Thermo Fisher Scientific
TMO
|
+$37.4M |
| 2 |
PepsiCo
PEP
|
+$33.7M |
| 3 |
Amazon
AMZN
|
+$19.2M |
| 4 |
Visa
V
|
+$16.5M |
| 5 |
Microsoft
MSFT
|
+$13.8M |
Sector Composition
| 1 | Technology | 21.73% |
| 2 | Healthcare | 16.78% |
| 3 | Financials | 16.25% |
| 4 | Consumer Discretionary | 15.23% |
| 5 | Communication Services | 10.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Philip Morris
PM
$259B
| $294K | 0.01% |
+1,851
| New | +$294K |
|
|
B
152
Barrick Mining Corporation
B
$50.3B
| $277K | 0.01% |
+14,231
| New | +$277K |
|
153
Elevance Health
ELV
$69.5B
| $272K | 0.01% |
+625
| New | +$272K |
|
154
UBS Group
UBS
$131B
| $272K | 0.01% |
8,949
-1,260
| -12% | -$38.3K |
|
155
Wynn Resorts
WYNN
$12.8B
| $270K | 0.01% |
+3,235
| New | +$270K |
|
156
Progressive
PGR
$143B
| $269K | 0.01% |
+950
| New | +$269K |
|
157
Expeditors International
EXPD
$17B
| $262K | 0.01% |
+2,179
| New | +$262K |
|
158
Lowe's Companies
LOW
$150B
| $261K | 0.01% |
+1,121
| New | +$261K |
|
159
ASML
ASML
$343B
| $252K | 0.01% |
+380
| New | +$252K |
|
160
VeriSign
VRSN
$26.9B
| $251K | 0.01% |
+987
| New | +$251K |
|
161
Packaging Corp of America
PKG
$19.1B
| $245K | 0.01% |
+1,235
| New | +$245K |
|
162
Aflac
AFL
$58.4B
| $243K | 0.01% |
+2,188
| New | +$243K |
|
163
iShares MSCI Japan ETF
EWJ
$15.8B
| $236K | 0.01% |
3,440
| – | – |
|
164
NVR
NVR
$22.5B
| $232K | 0.01% |
+32
| New | +$232K |
|
165
iRhythm Technologies
IRTC
$5.53B
| $229K | 0.01% |
2,188
-1,101
| -33% | -$115K |
|
166
Colgate-Palmolive
CL
$66.5B
| $228K | 0.01% |
+2,430
| New | +$228K |
|
167
T Rowe Price
TROW
$23B
| $226K | 0.01% |
+2,461
| New | +$226K |
|
168
Marriott International Class A Common Stock
MAR
$71.1B
| $224K | 0.01% |
+940
| New | +$224K |
|
169
Prudential Financial
PRU
$36.3B
| $223K | 0.01% |
2,000
| – | – |
|
170
Target
TGT
$40.4B
| $221K | 0.01% |
+2,118
| New | +$221K |
|
171
Biogen
BIIB
$21.2B
| $221K | 0.01% |
+1,614
| New | +$221K |
|
172
iShares Core S&P Small-Cap ETF
IJR
$85.2B
| $221K | 0.01% |
2,110
| – | – |
|
173
Zebra Technologies
ZBRA
$16.1B
| $218K | 0.01% |
772
| – | – |
|
174
Humana
HUM
$32.4B
| $214K | 0.01% |
+810
| New | +$214K |
|
175
Exxon Mobil
XOM
$492B
| $210K | 0.01% |
+1,769
| New | +$210K |
|